AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01042-07v1
52/3/1206    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kehrenberg, C.
Right arrow Articles by Schwarz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kehrenberg, C.
Right arrow Articles by Schwarz, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2008, p. 1206-1207, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01042-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Novel Variant of the qnrB Gene, qnrB12, in Citrobacter werkmanii{triangledown}


   LETTER
Top
 LETTER
REFERENCES
 
Three epidemiologically and clonally unrelated Citrobacter werkmanii isolates of poultry origin from Germany (Table 1) were investigated for the mechanisms responsible for decreased fluoroquinolone susceptibility. The MICs, determined by broth macrodilution (10), varied between 8 and >256 µg/ml for nalidixic acid and between 0.0625 and 1 µg/ml for ciprofloxacin (Table 1). CIT2 was additionally resistant to kanamycin. The quinolone resistance-determining regions of gyrA, gyrB, parC, and parE were amplified and sequenced (6). Nalidixic acid-resistant isolate CIT1 showed a Thr83Ile substitution in GyrA, previously reported to be sufficient for decreased fluoroquinolone susceptibility in Citrobacter isolates (11, 12, 16), and a Ser57Thr substitution in ParC, which was also seen in highly ciprofloxacin-susceptible Salmonella isolates (2). Another substitution, Leu88Gln, was detected in ParC of isolate CIT3, for which the MIC of ciprofloxacin was low, 0.0625 µg/ml (Table 1). A variable decrease in the (fluoro)quinolone MICs was detected in the presence of the efflux pump inhibitor Phe-Arg-β-naphthylamide (Table 1), suggesting a variable contribution of an efflux system(s) in determining the level of quinolone susceptibility.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Characteristics of the three Citrobacter isolates and of the E. coli clones harboring the qnrB12 genes

 
PCR-based detection of the genes qnrA, qnrS, and qnrB, as well as of the aminoglycoside/fluoroquinolone-modifying enzyme-encoding gene aac(6')-Ib-cr (3-8, 14), identified only a qnrB gene in all three C. werkmanii strains. A chromosomal location of this gene appeared most likely since repeated plasmid transformation-conjugation experiments using Escherichia coli CS1562 or E. coli HK225 RifR, respectively, yielded negative results (7), and Southern blot hybridization studies with plasmid profiles and with I-CeuI-digested genomic DNA gave a signal only with the largest I-CeuI fragment (approximately 800 kb) in each strain. Moreover, S1 nuclease digestion, followed by pulsed-field gel electrophoresis (1), did not identify any large qnrB-carrying plasmid which might comigrate with this 800-kb I-CeuI fragment (data not shown). Genomic DNA of isolate CIT1 was digested with restriction enzymes EcoRV, PvuI, SacII, and XhoII. The resulting fragments were religated and subjected to inverse PCR assays (with primers qnrB-inv-fw [5'-CGCACTGTGATTTGACCAATTC-3'] and qnrB-inv-rv [5'-CGCCATGGAGAGATCACAACT-3']). The amplicons were sequenced and assembled. Analysis of a 3,629-bp segment (accession number AM774474) revealed that the qnrB gene was located downstream of four open reading frames, pspF, pspA, pspB, and pspC, encoding phage shock proteins in a genetic background with similarity to Klebsiella pneumoniae plasmid pTN60013 (17). The qnrB gene was identified as a novel variant, designated qnrB12, which codes for a 215-amino-acid protein and exhibits the highest degree of nucleotide (98.9%) and amino acid (99.5%) sequence identity to the qnrB9 sequence from Citrobacter freundii (accession number EF653270).

To investigate the genetic background of the qnrB gene in the three Citrobacter isolates, additional PCR assays (with primers qnrB12-complete-fw [5'-TACCGCTGGATCTGCGTGA-3'] and qnrB12-complete-rv [5'-TGTATGTCACTTTAGCGGCTGAAG-3']) were conducted. The resulting 1,060-bp amplicons comprised the entire qnrB gene, as well as 234 bp upstream and 178 bp downstream. Sequencing confirmed the location of the qnrB gene in an identical background. The three qnrB genes exhibited >99% nucleotide sequence identity and 100% amino acid identity. The amplicons were cloned into vector pCR-BluntII-TOPO and transformed into the E. coli TOP10 recipient strain (Invitrogen, Karlsruhe, Germany). In the presence of the cloned qnrB12 gene, a 4-fold increase in the MICs of nalidixic acid and a 32-fold increase in the MICs of ciprofloxacin were detected (Table 1).

So far, few reports have suggested a chromosomal location of the commonly plasmid-borne qnr genes (15) and a chromosomally located origin of the genes was only confirmed in Shewanella algae (13). Our hybridization data, in combination with the sequence data of the qnrB12 flanking regions, led to the assumption that a qnrB12-carrying plasmid similar to pTN60013 from K. pneumoniae might have been, at least in part, integrated into the chromosomal DNAs of these C. werkmanii strains.


   ACKNOWLEDGMENTS
 
We thank Vera Nöding for excellent technical assistance.


   FOOTNOTES
 
{triangledown} Published ahead of print on 17 December 2007. Back


   REFERENCES
Top
 LETTER
 REFERENCES
 

  1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.[CrossRef][Medline]
  2. Baucheron, S., E. Chaslus-Dancla, A. Cloeckaert, C. H. Chiu, and P. Butaye. 2005. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan. Antimicrob. Agents Chemother. 49:862-863.[Free Full Text]
  3. Gay, K., A. Robicsek, J. Strahilevitz, C. H. Park, G. Jacoby, T. J. Barrett, F. Medalla, T. M. Chiller, and D. C. Hooper. 2006. Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica. Clin. Infect. Dis. 43:297-304.[CrossRef][Medline]
  4. Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49:801-803.[Abstract/Free Full Text]
  5. Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.[Abstract/Free Full Text]
  6. Kehrenberg, C., A. de Jong, S. Friederichs, A. Cloeckaert, and S. Schwarz. 2007. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J. Antimicrob. Chemother. 59:886-892.[Abstract/Free Full Text]
  7. Kehrenberg, C., S. Friederichs, A. de Jong, G. B. Michael, and S. Schwarz. 2006. Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis. J. Antimicrob. Chemother. 58:18-22.[Abstract/Free Full Text]
  8. Martínez-Martínez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.[CrossRef][Medline]
  9. Michael, G. B., M. Cardoso, and S. Schwarz. 2006. Molecular analysis of Salmonella enterica subsp. enterica serovar Agona isolated from slaughter pigs. Vet. Microbiol. 112:43-52.[CrossRef][Medline]
  10. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard, 2nd edition. NCCLS document M31-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
  11. Navia M. M., J. Ruiz, A. Ribera, M. T. de Anta, and J. Vila. 1999. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii. J. Antimicrob. Chemother. 44:743-748.[Abstract/Free Full Text]
  12. Nishino, Y., T. Deguchi, M. Yasuda, T. Kawamura, M. Nakano, E. Kanematsu, S. Ozeki, and Y. Kawada. 1997. Mutations in the gyrA and parC genes associated with fluoroquinolone resistance in clinical isolates of Citrobacter freundii. FEMS Microbiol. Lett. 154:409-414.[CrossRef][Medline]
  13. Poirel, L., J. M. Rodriguez-Martinez, H. Mammeri, A. Liard, and P. Nordmann. 2005. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49:3523-3525.[Abstract/Free Full Text]
  14. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
  15. Rodriguez-Martinez, J. M., L. Poirel, A. Pascual, and P. Nordmann. 2006. Plasmid-mediated quinolone resistance in Australia. Microb. Drug Resist. 12:99-102.[CrossRef][Medline]
  16. Tavío, M., J. Vila, J. Ruiz, G. Amicosante, N. Franceschini, A. M. Martin-Sanchez, and M. T. de Anta. 2000. In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition. J. Antimicrob. Chemother. 45:521-524.[Abstract/Free Full Text]
  17. Verdet, C., Y. Benzerara, V. Gautier, O. Adam, Z. Ould-Hocine, and G. Arlet. 2006. Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob. Agents Chemother. 50:607-617.[Abstract/Free Full Text]
Corinna Kehrenberg*
Institute of Farm Animal Genetics
Friedrich-Loeffler-Institute (FLI)
Höltystrasse 10
31535 Neustadt-Mariensee, Germany

Sonja Friederichs
Anno de Jong
Bayer HealthCare AG
Animal Health Division
Clinical Research and Development Antiinfectives
51368 Leverkusen, Germany

Stefan Schwarz
Institute of Farm Animal Genetics
Friedrich-Loeffler-Institute (FLI)
Höltystrasse 10
31535 Neustadt-Mariensee, Germany

* Phone: 49-5034-871242, Fax: 49-5034-871246, E-mail: corinna.kehrenberg{at}fal.de

Antimicrobial Agents and Chemotherapy, March 2008, p. 1206-1207, Vol. 52, No. 3
0066-4804/08/$08.00+0     doi:10.1128/AAC.01042-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01042-07v1
52/3/1206    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kehrenberg, C.
Right arrow Articles by Schwarz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kehrenberg, C.
Right arrow Articles by Schwarz, S.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS